Transphorm Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Transphorm in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Transphorm stock.
View analyst ratings for Transphorm or view top-rated stocks.

Wall Street analysts have given Transphorm a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Transphorm wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Transphorm saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 6,100 shares, a decline of 58.5% from the March 15th total of 14,700 shares. Based on an average trading volume of 178,300 shares, the days-to-cover ratio is presently 0.0 days.
View Transphorm's Short Interest.

Transphorm is scheduled to release its next quarterly earnings announcement on Tuesday, June 8th 2021.
View our earnings forecast for Transphorm.

Transphorm, Inc. (OTCMKTS:TGAN) released its earnings results on Monday, March, 8th. The company reported ($0.13) EPS for the quarter, missing the Zacks' consensus estimate of ($0.11) by $0.02. The business had revenue of $2 million for the quarter, compared to the consensus estimate of $1.95 million.
View Transphorm's earnings history.

2 brokers have issued 12-month price objectives for Transphorm's shares. Their forecasts range from $8.00 to $9.50. On average, they anticipate Transphorm's stock price to reach $8.75 in the next twelve months. This suggests a possible upside of 94.4% from the stock's current price.
View analysts' price targets for Transphorm or view top-rated stocks among Wall Street analysts.

Some companies that are related to Transphorm include ReneSola (SOL), Maxeon Solar Technologies (MAXN), Ebang International (EBON), NeoPhotonics (NPTN), Atomera (ATOM), Netlist (NLST), AXT (AXTI), Ascent Solar Technologies (ASTI), DSP Group (DSPG), NVE (NVEC), VIA optronics (VIAO), POET Technologies (POETF), Beam Global (BEEM), EMCORE (EMKR) and Resonant (RESN).
View all of TGAN's competitors.

Transphorm trades on the OTCMKTS under the ticker symbol "TGAN."

Shares of TGAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TGAN stock can currently be purchased for approximately $4.50.

Transphorm has a market capitalization of $182.43 million.

Transphorm employs 91 workers across the globe.

The official website for Transphorm is www.transphormusa.com.

Transphorm is headquartered at 75 CASTILIAN DRIVE, GOLETA CA, 93117.

Transphorm's mailing address is 75 CASTILIAN DRIVE, GOLETA CA, 93117. The company can be reached via phone at 805 456 1300 or via email at [email protected]